Featured articles
vivoVerse at the Society of Toxicology Annual Meeting in Nashville
March 2, 2023
The 2023 Society of Toxicology (SOT) Annual Meeting is coming up this month, and we will be attending! The SOT ...
READ MORE →
vivoVerse Announces Intent to Grant Utility Patent on the vivoChip® by the European Patent Office
August 5, 2020
Patent covers the vivoChip® invention that vivoVerse licensed for use in immobilization of C. elegans for high resolution imaging. AUSTIN, ...
READ MORE →
vivoVerse moves into new HQ
May 5, 2021
vivoVerse (formerly operating as Newormics) has expanded its base of operations into a customized, newly refurbished space in Austin, Texas. ...
READ MORE →
vivoVerse awarded SBIR Phase II grant from the NIMH
July 8, 2020
vivoVerse (formerly operating as Newormics) is excited to announce it has been awarded a $2.25M Phase II SBIR grant from ...
READ MORE →
More articles
Newormics resumes operations
August 20, 2020
Dear Colleagues, Customers, and Collaborators: At our Newormics location in Austin, TX, we have been allowed to re-open. We have ...
READ MORE →
COVID-19 UPDATE
March 27, 2020
Dear Customers, Colleagues, and Collaborators: At Newormics, we recognize that combating the spread of this new virus requires a global ...
READ MORE →
Newormics launches new vivoChips for early stage worms
October 14, 2019
Early larval stages of C. elegans (L1 to L3 and Dauer) have always been among the hardest to immobilize and ...
READ MORE →
DDNews features Newormics in their latest issue in a special report on drug screening
August 10, 2019
The research of Newormics is featured in a special report in the July 2019 issue of DDNews in an article ...
READ MORE →
Newormics at the 2019 UK C. elegans meeting
July 30, 2019
Newormics is exhibiting at the 2019 UK C. elegans meeting at Imperial College London on September 16th. Come meet us ...
READ MORE →
Newormics awarded an SBIR Phase I grant from the NIEHS
July 9, 2019
Newormics was awarded an SBIR Phase I grant from the National Institute of Environmental Health Sciences (NIEHS) for the project ...
READ MORE →
Newormics at the 2019 International C. elegans Conference
June 20, 2019
Newormics is exhibiting at the 22nd International C. elegans Conference at UCLA, Los Angeles from 20th June - 24th June. ...
READ MORE →
Newormics selected for the NIH I-Corps
June 18, 2019
Newormics was selected for the NIH I-Corps April-June 2019 cohort. Over the course of the I-Corps program, the team had ...
READ MORE →
Newormics awarded SBIR Phase I grant from the NIMH
October 9, 2018
Newormics was awarded an SBIR Phase I grant from the National Institute of Mental Health (NIMH) for the project "A ...
READ MORE →
